Trademark: 86361619
Status Date
Tuesday, July 17, 2018
Registration Number
5519804
Registration Date
Tuesday, July 17, 2018
Filing Date
Friday, August 8, 2014
Published for Opposition
Tuesday, March 7, 2017
40 Custom manufacture of pharmaceuticals; manufacturing services for others in the field of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; professional consultancy in the field of biotechnical and biomedical treatment of materials; professional consultancy in the field of tabletting technology and injection molding technology; professional consultancy in the field of pharmaceutical with controlled release properties and/or abuse-deterrent properties; all the aforesaid relating to humans and none relating to animals, nor being for veterinary purposes
5 Drug delivery preparations used in the manufacture of orally administered pharmaceuticals, namely, drug delivery technology in the form of injection molded hard oral tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery preparation technology used in manufacturing, namely, a pharmaceutical and medical injection molded hard oral tablet used for the controlled release of a wide variety of therapeutic agents; drug delivery agents in the form of injection molded hard oral tablets used in the manufacture of orally administered pharmaceuticals that provide controlled release/delivery of the active ingredients for a wide variety of pharmaceutical preparations and active ingredients at a constant rate of release; pharmaceutical preparation and medicine technology used in manufacturing, namely, an abuse-deterrent drug delivery system, namely, injection molded hard oral tablets that resist crushing, grinding, and dissolving and/or controlling the release of the active ingredients for a wide variety of pharmaceuticals; all the aforesaid relating to humans and none relating to animals, nor being for veterinary purposes
42 Pharmaceutical drug research and development services; pharmaceutical products development; pharmaceutical research and development; development of tabletting technology and injection molding technology for others; development of pharmaceutical modified and controlled release systems for others; development of dispersed drug systems for others; development of abuse-deterrent drug system for others; all the aforesaid relating to humans and none relating to animals, nor being for veterinary purposes
Jul 17, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 27, 2020
Assignment Of Ownership Not Updated Automatically
May 22, 2019
Assignment Of Ownership Not Updated Automatically
Jul 17, 2018
Registered-Principal Register
Jun 9, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 8, 2018
Allowed Principal Register - Sou Accepted
Jun 8, 2018
Data Modification Completed
May 16, 2018
Teas/Email Correspondence Entered
May 16, 2018
Correspondence Received In Law Office
May 9, 2018
Teas Request For Reconsideration Received
May 3, 2018
Notification Of Final Refusal Emailed
May 3, 2018
Final Refusal E-Mailed
May 3, 2018
Su - Final Refusal - Written
May 3, 2018
Teas/Email Correspondence Entered
May 3, 2018
Correspondence Received In Law Office
May 1, 2018
Teas Response To Office Action Received
Nov 4, 2017
Notification Of Non-Final Action E-Mailed
Nov 4, 2017
Non-Final Action E-Mailed
Nov 4, 2017
Su - Non-Final Action - Written
Oct 24, 2017
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2017
Statement Of Use Processing Complete
Oct 16, 2017
Use Amendment Filed
Oct 23, 2017
Sou Extension 1 Granted
Oct 16, 2017
Sou Extension 1 Filed
Oct 23, 2017
Case Assigned To Intent To Use Paralegal
Oct 16, 2017
Teas Extension Received
Oct 16, 2017
Teas Statement Of Use Received
May 2, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2017
Published For Opposition
Feb 15, 2017
Notification Of Notice Of Publication E-Mailed
Jan 31, 2017
Law Office Publication Review Completed
Jan 13, 2017
Approved For Pub - Principal Register
Jan 12, 2017
Examiner's Amendment Entered
Jan 12, 2017
Notification Of Examiners Amendment E-Mailed
Jan 12, 2017
Examiners Amendment E-Mailed
Jan 12, 2017
Examiners Amendment -Written
Jan 6, 2017
Teas/Email Correspondence Entered
Jan 6, 2017
Correspondence Received In Law Office
Dec 21, 2016
Teas Response To Suspension Inquiry Received
Aug 22, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 22, 2016
Teas Change Of Owner Address Received
Jun 25, 2016
Notification Of Letter Of Suspension E-Mailed
Jun 25, 2016
Letter Of Suspension E-Mailed
Jun 25, 2016
Suspension Letter Written
Jun 3, 2016
Teas/Email Correspondence Entered
Jun 3, 2016
Correspondence Received In Law Office
May 31, 2016
Teas Response To Suspension Inquiry Received
May 25, 2016
Notification Of Inquiry As To Suspension E-Mailed
May 25, 2016
Inquiry To Suspension E-Mailed
May 25, 2016
Suspension Inquiry Written
May 4, 2016
Suspension Checked ¿ To Attorney For Action
Apr 28, 2016
Assigned To Lie
Oct 8, 2015
Notification Of Letter Of Suspension E-Mailed
Oct 8, 2015
Letter Of Suspension E-Mailed
Oct 8, 2015
Suspension Letter Written
Sep 17, 2015
Teas/Email Correspondence Entered
Sep 17, 2015
Correspondence Received In Law Office
Sep 17, 2015
Teas Response To Suspension Inquiry Received
Jun 13, 2015
Notification Of Letter Of Suspension E-Mailed
Jun 13, 2015
Letter Of Suspension E-Mailed
Jun 13, 2015
Suspension Letter Written
May 23, 2015
Teas/Email Correspondence Entered
May 22, 2015
Correspondence Received In Law Office
May 22, 2015
Teas Response To Office Action Received
Nov 24, 2014
Notification Of Non-Final Action E-Mailed
Nov 24, 2014
Non-Final Action E-Mailed
Nov 24, 2014
Non-Final Action Written
Nov 22, 2014
Assigned To Examiner
Aug 19, 2014
New Application Office Supplied Data Entered
Aug 12, 2014
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
